^
+ Follow NORTH CENTRAL CANCER TREATMENT GROUP Tag
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 551569
                    [Title] => Greater chances of cure for patients with breast cancer
                    [Summary] => 

Roche announced recently its new long-term follow up-data from two large pivotal studies evaluating adjuvant trastuzumab in HER2-positive early- stage breast cancer presented at the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).

[DatePublished] => 2010-02-22 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Freeman Cebu Lifestyle [SectionUrl] => cebu-lifestyle [URL] => ) ) )
NORTH CENTRAL CANCER TREATMENT GROUP
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 551569
                    [Title] => Greater chances of cure for patients with breast cancer
                    [Summary] => 

Roche announced recently its new long-term follow up-data from two large pivotal studies evaluating adjuvant trastuzumab in HER2-positive early- stage breast cancer presented at the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).

[DatePublished] => 2010-02-22 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Freeman Cebu Lifestyle [SectionUrl] => cebu-lifestyle [URL] => ) ) )
abtest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with